Effects of 'Seroquel' (quetiapine) on platelet serotonin-2 binding in schizophrenia.
Faustman
W O
WO
Ringo
D L
DL
Lauriello
J
J
Lim
K O
KO
Pfefferbaum
A
A
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004311:Double-Blind Method; D006801:Humans; D007700:Kinetics; D008297:Male; D011569:Psychiatric Status Rating Scales; D000069348:Quetiapine Fumarate; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism*; D012559:Schizophrenia / Q000097:blood / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D000069348:Quetiapine Fumarate